Companies involved in early drug efficacy screening and preclinical studies in inflammation need high quality, rigorously controlled healthy human and patient clinical samples to understand the risks and potential of therapeutic candidates.
CellMade is assembling the World’s first inflammation biobank, containing blood-derived cells, primary human cells and tissues that are relevant for monitoring inflammatory processes. Our established clinical networks and tissue acquisition protocols enable us to collect materials and associated clinical data that is essential for gaining useful and reliable human data in drug discovery.
Pharmaceutical and biotechnology clients can gain access to our inflammation biobank in two main ways:
If you are interested in gaining rapid access to highly curated, high quality human-origin blood and biopsy samples for your inflammation R&D programs, please talk to us.